No items found.
Helimeds is a newer telehealth platform (founded 2024, based in San Marcos, California) that distinguishes itself with a no-subscription model for compounded GLP-1 medications. Rather than monthly recurring charges, patients pay upfront for 12-week treatment plans with no automatic billing or recurring charges — when you're ready for another cycle, you place a new order. They offer compounded semaglutide and additive-free compounded tirzepatide, with all medications third-party tested through FDA and DEA registered labs. Beyond weight loss, Helimeds also offers Sermorelin, MIC+B12, NAD+, and sexual health treatments. Notably, Helimeds was not among the 55+ providers that received FDA warning letters in September 2025.
The one-time payment structure is refreshing in a market dominated by subscriptions. Compounded semaglutide starts at $99/month for the starter dose (paid upfront as a $297 12-week plan) and $199/month for higher doses. Compounded tirzepatide runs $447 upfront for the 12-week starter plan ($149/month) or $697 for higher doses ($232/month). The entire 3-month semaglutide supply arrives in a single vial, and all plans include free shipping, online text consultations, and no insurance requirement. The additive-free tirzepatide with third-party lab testing is a quality differentiator. Content is medically reviewed by Dr. Tomas Salinas Aguilera, MD.
As a platform founded in 2024, Helimeds has a limited review history — 54 Trustpilot reviews is a small sample, and long-term reliability is still being established. Some users have reported that app instructions and program details could be clearer for new patients, particularly around the single-vial dosing format. At least one reviewer noted that after the initial 12-week plan, continuation pricing wasn't competitive enough and they switched providers. Shipping delays during severe weather events have also been reported, though Helimeds was transparent about the FedEx disruptions involved.
Helimeds is a strong choice for patients who prefer paying upfront over monthly subscriptions and value medication quality assurance. The competitive semaglutide entry point ($99/month starter), third-party tested additive-free tirzepatide, and no-subscription billing model make it appealing for patients who want a straightforward GLP-1 program without recurring billing surprises. The lack of an FDA warning letter is another quiet positive. The main limitation is a short track record — give it time to build a larger review base.
Helimeds' compounded semaglutide starts at $99/month for the starter dose, paid upfront as a 12-week plan. Higher doses run $199/month. Compounded tirzepatide starts at $447 for a 12-week starter plan (about $149/month). Higher doses run $697 for 12 weeks (about $232/month). This is not a subscription — you're charged once with no automatic recurring billing.
Helimeds offers compounded semaglutide and compounded tirzepatide, both injectable GLP-1 medications prepared by licensed U.S. compounding pharmacies. Their tirzepatide is additive-free, and all medications undergo third-party quality testing through FDA and DEA registered labs. They also offer Sermorelin, MIC+B12, and NAD+.
No. You pay once for your selected treatment plan with no automatic billing or recurring charges. They offer 12-week plans where the entire medication supply ships together, and you reorder when you're ready for the next cycle.
Complete a 5-minute online health assessment, then a licensed provider reviews your information and creates a personalized treatment plan. If prescribed, your medication ships directly to your door from a licensed compounding pharmacy with free shipping included.
Helimeds works with licensed healthcare providers and licensed U.S. compounding pharmacies. Their medications undergo third-party testing through FDA and DEA registered labs. They hold a 4.5-star Trustpilot rating from 54 reviews — a limited sample as a newer platform founded in 2024, but early feedback is positive.
